Skip to main navigation Skip to search Skip to main content

Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3.

  • S Pianko
  • , S Zeuzem
  • , WL Chuang
  • , GR Foster
  • , SK Sarin
  • , R Flisiak
  • , Chuan-mo Lee
  • , P Andreone
  • , T Piratvisuth
  • , S Shah
  • , A. Sood
  • , J George
  • , M Gould
  • , P Komolmit
  • , S Thongsawat
  • , T Tanwandee
  • , J Rasenack
  • , Y Li
  • , M Pang
  • , Y Yin
    • G Feutren, IM Jacobson

Research output: Contribution to journal › Journal Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3.'. Together they form a unique fingerprint.
Sort by

Nursing and Health Professions

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science